MétaCan
Menu
← Back to cohort
Record W4406687400 · doi:10.1093/ecco-jcc/jjae190.0127

DOP088 Speed of disease progression as hallmark of Crohn’s Disease Severity: The rapid and slow progressors.

2025· article· en· W4406687400 on OpenAlexaboutno aff
C Vuckovic, Anneline Cremer, Charlotte Minsart, Leila Amininejad, Jérémie Bottieau, Denis Franchimont, Claire Liefferinckx

Bibliographic record

VenueJournal of Crohn s and Colitis · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCrohn's diseaseDiseaseInternal medicineGastroenterology

Abstract

fetched live from OpenAlex

Abstract Background The natural course of Crohn's Disease (CD) can involve the development of intra-abdominal strictures and fistulae (Montreal B2 and B3 phenotypes, respectively). Yet, the speed of disease progression to these phenotypes may differ among patients. This study retrospectively analyses a large cohort of CD patients with luminal phenotype at diagnosis (Montreal B1) and evaluates the speed of disease progression to B2/B3 phenotypes, in a tertiary centre in Belgium. Methods A total of 1,262 IBD patients were screened from the 3000+ inflammatory bowel diseases (IBD) patient’s clinics. Among the 516 CD patients diagnosed after 1999 and meeting the inclusion criteria, 372 presented with a B1 phenotype at diagnosis. Of these, 108 patients progressed to B2/B3 phenotypes during follow-up (FU) and were analysed. Demographics, dynamic disease characteristics and treatment adaptations were collected. Patients were stratified into rapid progressors (within 5 years) and slow progressors (beyond 5 years), based on the median progression time in our cohort of 108 patients (median 5 years [1.8-9.9], Figure 1a). Statistical analyses were performed using Prism. Results Of the 108 patients progressing to B2/B3 phenotypes, 56 (52%) were rapid progressors (median time 1.8 years [0.8–3.5]) and 52 (48%) were slow progressors (median time 10 years [7.0–12.6]; p<0.0001) (Figure 1b). Rapid progressors were older at CD diagnosis (median age 25 years [21–38] vs 19 years [15–24], p<0.0001), as paediatric CD was more prevalent in slow progressors (33% vs 5%, p=0.0003). Although both groups required biologics and surgeries in similar proportions, rapid progressors started biologics earlier (median 1.3 years [0.3–3.1] vs 5.6 years [2.7–8.9], p<0.0001) and underwent surgery for disease progression earlier (median 2 years [1.1–4.3] vs 10 years [6.9–13.4], p<0.0001). All surgeries occurred after B2/B3 progression and slow progressors underwent surgery later after initiating biologics (median 6.7 year [2–9.5] vs 1.2 year [0.3–2.7], p<0.0001 – Figure 1d). Conclusion CD patients with initial B1 phenotype progressing to B2/B3 phenotypes can be classified as rapid and slow progressors based on their speed of progression to these phenotypes. Rapid progressors demonstrate a more aggressive disease course, with earlier biologics initiation and need for surgery. The description of disease progression may uncover a new dynamic disease phenotype of disease severity that is often overlooked or lacking in the current reported cohort and population-based studies. Stratification by the speed of progression may better define patients with severe disease, potentially guiding tailored therapeutic strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.258
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→